JAZZ
Jazz Pharmaceuticals PLC
240.70$
-1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.0% | +12.3% | +8.8% | +16.8% | +14.3% | +9.3% | +30.9% | +18.3% | +4.8% | +6.1% | +4.9% | |
| – | -12.7% | +2.8% | +4.6% | +10.3% | +5.3% | +16.4% | +196.0% | +22.6% | -19.4% | +2.3% | +12.9% | |
| – | +15.8% | +13.1% | +9.1% | +17.3% | +14.9% | +8.9% | +19.8% | +17.5% | +9.0% | +6.6% | +3.9% | |
| – | +58.8% | +20.0% | +22.3% | +14.2% | +32.3% | +11.9% | +50.8% | +16.7% | +43.9% | +4.0% | -11.5% | |
| – | +17.6% | +12.0% | +8.5% | +25.6% | +7.8% | +15.9% | +69.9% | -2.4% | -6.1% | +4.1% | +30.6% | |
| – | -17.0% | +10.8% | +23.9% | +17.9% | +30.0% | +22.3% | +35.2% | +28.2% | -11.4% | +3.1% | +21.8% | |
| – | +159.8% | +16.4% | -10.6% | +16.3% | -13.4% | -29.0% | -55.0% | -138.5% | – | +23.9% | -68.7% | |
| – | +8.0% | +8.8% | +25.5% | +1.0% | -7.9% | +38.0% | +179.6% | +3.4% | +0.4% | -17.7% | -18.1% | |
| – | +187.6% | +22.1% | -17.3% | +19.8% | -14.6% | -39.6% | -141.7% | – | – | +58.9% | -234.1% | |
| – | +12.9% | +27.1% | -135.3% | – | -191.3% | – | +544.8% | -173.4% | – | – | – | |
| – | +464.4% | +20.4% | +22.9% | -8.4% | +17.1% | -54.4% | -237.9% | – | – | +35.0% | -163.6% | |
| – | +14.1% | +13.2% | +3.3% | +19.7% | +8.6% | +3.1% | -1.5% | +42.9% | -1.3% | +5.0% | -92.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.